吉林制药没有尽头的重组之路管理(Jilin pharmaceutical no end of the restructuring of the road management).doc

吉林制药没有尽头的重组之路管理(Jilin pharmaceutical no end of the restructuring of the road management).doc

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
吉林制药没有尽头的重组之路管理(Jilin pharmaceutical no end of the restructuring of the road management)

吉林制药没有尽头的重组之路管理(Jilin pharmaceutical no end of the restructuring of the road management) In March 28th, as has long been suspended in Jilin Pharmaceutical (000545.SZ) the date of resumption of trading, investors did not due to a major restructuring of the resumption of joy, because they have been numb: the reorganization of the four three years, four failed. Wolf come the reorganization of the way, but also to Jilin pharmaceutical was dubbed A shares poison and most Huyou listed company name. Jilin pharmaceutical is no longer a pharmaceutical company, because the focus of attention is restructuring, Ampang consulting pharmaceutical industry analyst dawn told times weekly reporter. Where is the fifth reorganization road? March 22, 2011 Jilin pharmaceutical company released announcement: the company is planning a major asset reorganization, the company stock has been suspended since February 25th, and is currently on the major asset restructuring matters in-depth analysis and demonstration, etc.. This is the third time since the Jilin pharmaceutical company issued the reorganization announcement in March, and it is also the fifth reorganization announcement in three years. The announcement came just 19 days before the last restructuring failed. After Jilin pharmaceutical declared: affected by the macro-control of real estate, after restructuring and broadcasting group does not have the basis for the implementation of the application documents, the relevant parties to apply to the Commission to withdraw the major asset reorganization In early 2010, as the fourth reorganization of Jilin pharmaceutical, Jilin pharmaceutical intends to use all existing assets, liabilities and related business sold to Jilin Kimcheon group, real estate broadcasting to all shareholders of non-public offering of shares to buy its holdings of 100% stake in real estate broadcasting. If the reorganization is completed, Jilin pharmaceutical will be hollowed out, the original pharmaceutical busine

文档评论(0)

jgx3536 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6111134150000003

1亿VIP精品文档

相关文档